Manufacturing And Sustainability
-
Innovation Of Novel Purification Strategies
6/2/2025
In this webinar, we present the development of a novel scavenging resin for clusterin, a persistent CHO host cell protein commonly observed in monoclonal antibody manufacturing processes.
-
Streamlining Vaccine Development, Production With Modality-Specific Purification Tools
6/5/2025
Novel vaccine purification tools are speeding up development for mRNA, viral vectors, and VLPs. Learn how specific chromatography resins can enhance rapid screening and downstream processing.
-
Why Clinical Holds Happen
2/21/2023
The volume of clinical holds doled out by the FDA has skyrocketed in recent years. In this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, NDA Partners Expert Consultant Daniela Drago, Ph.D. and Umoja Biopharma VP of Regulatory Affairs Helen Kim explain clinical holds and discuss why they happen.
-
Multi-Omics And Bioinformatics In Cell Culture Media Design
6/16/2025
Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.
-
CHO Solutions Day Part 1
5/29/2025
This CHO Solutions Day presentation offers valuable insights into new media and feed systems, a successful scale-up story, and how multi-omics analysis can enhance your cell culture.
-
Inside Bioprocessing: Multi-Omics
6/16/2025
Dive into multi-omics analysis with Paul Gulde, Chengjian Tu, and Femi Egbebi. In biopharmaceutical production, meeting the unique nutrient requirements of the cells is central to achieving optimal results.
-
Validation Of A qPCR Assay For Host Cell DNA Quantitation
6/9/2025
Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.
-
Process Liquids And Buffers Offering
5/2/2024
Whether you are a researcher, scientist, or industry professional, this video will provide valuable insights into our large volume liquids manufacturing capabilities.
-
Addressing Post-Translational Modifications In Novel Protein Therapeutics
9/13/2024
Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.
-
Environmental Sustainability In Bioprocessing
7/11/2023
This conversation focuses on sustainability in bioprocessing and the exciting advancements happening in the space, featuring practical examples and case studies.